Clinical Trials
12 trialsNCT07431216 2026-03-30
A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression
Starlight Therapeutics Inc.
Phase 1/2 Not yet recruiting
NCT07364422 2026-01-23
To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer
Onconic Therapeutics Inc.
Phase 1/2 Not yet recruiting
NCT06690775 2025-12-23
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
TORL Biotherapeutics, LLC
Phase 2 Recruiting
NCT03401385 2025-10-21
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
Daiichi Sankyo
Phase 1 Active not recruiting
NCT00547157 2017-03-15
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Amgen
Phase 2 Completed
NCT01544322 2015-06-18
ME-344-001
MEI Pharma, Inc.
Phase 1 Completed
NCT01711398 2015-02-12
IP N02
Elro Pharma
Phase 1/2 Completed
NCT01558687 2014-02-04
Cilengitide Imaging Trial in Glioblastoma
Merck KGaA, Darmstadt, Germany
Phase 1 Terminated
NCT01401868 2013-06-24
Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
MEI Pharma, Inc.
Phase 1 Completed
NCT00087854 2008-04-23
Study of Individualized Amonafide to Treat Prostate Cancer
Xanthus Pharmaceuticals, Inc.
Phase 1/2 Completed
NCT00285675 2006-05-31
Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
Novacea
Phase 2 Unknown
NCT00035334 2006-02-14
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
Bellus Health Inc. - a GSK company
Phase 2/3 Completed